Candidaemia in a large teaching hospital: A clinical audit

QJM: An International Journal of Medicine

Volumn 99, Issue 10, 2006, Pages 655-663

  Aliyu, Sani H ^a   Enoch, D A ^a   Abubakar, I I ^b   Ali, R ^a   Carmichael, A J ^a   Farrington, M ^a   Lever, A M L ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ADULT; AGED; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDEMIA; CATHETER CARE; CENTRAL VENOUS CATHETER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG SENSITIVITY; FEMALE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITAL CARE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD; MORTALITY; MYCOSIS; NEWBORN; NONHUMAN; OUTCOME ASSESSMENT; PATIENT TRANSPORT; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; PUBLICATION; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TREATMENT DURATION;

EID: 33749605635     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcl087     Document Type: Article

References (37)

1. NINSS Partnership. Surveillance of hospital-acquired bacteraemia in English hospitals 1997-2002. London, Health Protection Agency, 2002.
2. Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003; 54:18-24.
3. Schelenz S, Gransden WR. Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period. Mycoses 2003; 46:390-6.
4. Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsch SM. Excess mortality, hospital stay, and cost due to candidemia: A case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005; 26:540-7.
5. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002; 35:627-30.
6. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24:1122-8.
7. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J Hosp Infect 2002; 50:56-65.
8. Denning DW, Kibbler CC, Barnes RA. British Society for Medical Mycology. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003; 3:230-40.
9. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38:161-89.
10. Patel M, Kunz DF, Trivedi VM, Jones MG, Moser SA, Baddley JW. Initial management of candidemia at an academic medical center: Evaluation of the IDSA guidelines. Diagn Microbiol Infect Dis 2005; 52:29-34.
11. McCabe WR, Jackson GG. Gram-negative bacteraemia. Arch Intern Med 1962; 110:847-55.
12. Puzniak L, Teutsch S, Powderly W, Polish L. Has the epidemiology of nosocomial candidemia changed? Infect Control Hosp Epidemiol 2004; 25:628-33.
13. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, Calandra T, Glauser MP, Tauber MG, Pittet D. Fungal Infection Network of Switzerland. Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991-2000. Clin Infect Dis 2004; 38:311-20.
14. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, Messer SA. Group. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39:3254-9.
15. Boo TW, O'Reilly B, O'Leary J, Cryan B. Candidaemia in an Irish tertiary referral hospital: Epidemiology and prognostic factors. Mycoses 2005; 48:251-9.
16. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, Biraghi E, Canton E, Zimmermann K, Seaton S, Grillot R. ECMM Working Group on Candidaemia. Epidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23:317-22.
17. Almirante B, Rodriguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005; 43:1829-35.
18. Tortorano AM, Biraghi E, Astolfi A, Ossi C, Tejada M, Farina C, Perin S, Bonaccorso C, Cavanna C, Raballo A, Grossi A; FIMUA Candidemia Study Group. European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: Report from one Italian region. J Hosp Infect 2002; 51:297-304.
19. Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M, Pfaller M, Edwards JE Jr, Jarvis W, Dawson J, Wenzel RP. National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29:253-8.
20. Nguyen MH, Peacock JE Jr, Tanner DC, Morris AJ, Nguyen ML, Snydman DR, Wagener MM, Yu VL. Therapeutic approaches in patients with candidemia: evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995; 155:2429-35.
21. Luzzati R, Allegranzi B, Antozzi L, Masala L, Pegoraro E, Azzini A, Concia E. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 2000; 19:602-7.
22. Karlowicz MG, Hashimoto LN, Kelly RE Jr, Buescher ES. Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics 2000; 106:e63.
23. Shetty SS, Harrison LH, Hajjeh RA, Taylor T, Mirza SA, Schmidt AB, Sanza LT, Shutt KA, Fridkin SK. Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000. Pediatr Infect Dis J 2005; 24:601-4.
24. Roilides E, Farmaki E, Evdoridou J, Dotis J, Hatziioannidis E, Tsivitanidou M, Bibashi, E, Filioti I, Sofianou D, Gil-Lamaignere C, Mueller FM, Kremenopoulos G. Neonatal candidiasis: Analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis 2004; 23:745-50.
25. Perry JL, Miller GR. Umbelliferyl-labeled galactosaminide as an aid in identification of Candida albicans. J Clin Microbiol 1987; 25:2424-5.
26. Dealler SF. Candida albicans colony identification in 5 minutes in a general microbiology laboratory. J Clin Microbiol 1991; 29:1081-2.
27. Merlino J, Tambosis E, Veal D. Chromogenic tube test for presumptive identification or Confirmation of Isolates as Candida albicans. J Clin Microbiol 1998; 36:1157-9.
28. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15:414-21.
29. Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J. Caspofungin Invasive Candidiasis Study Group. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347:2020-9.
30. Kullberg BJ, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Rex JH, Cleary JD, Rubinstein E, Church LW, Brown JM, Schlamm HT, Oborska IT, Hilton F, Hodges MR. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: A randomised non-inferiority trial. Lancet 2005; 366:1435-42.
31. Francis P, Walsh T. Evolving role of flucytosine in immunocompromised patients - new insights into safety, pharmacokinetics, and antifungal therapy. Clin Infect Dis 1992; 15:1003-18.
32. Smego RA Jr, Perfect JR, Durack DT. Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. Rev Infect Dis 1984; 6:791-801.
33. Marr B, Gross S, Cunningham C, Weiner L. Candidal sepsis and meningitis in a very-low-birth-weight infant successfully treated with fluconazole and flucytosine. Clin Infect Dis 1994; 19:795-6.
34. Vincent JL, Anaissie E, Bruining H, Demajo W, el-Ebiary M, Haber J, Hiramatsu Y, Nitenberg G, Nystrom PO, Pittet D, Rogers T, Sandven P, Sganga G, Schaller MD, Solomkin J. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998; 24:206-16.
35. Rex JH, Pappas PG, Karchmer AW, et al. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in non-neutropenic subjects. Clin Infect Dis 2003; 36:1221-8.
36. Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 1993; 17:103-9.
37. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team. A randomized controlled study. Arch Intern Med 1998; 158:473-7.